发现一个肠道细菌代谢途径,驱动α-Synuclein聚合
Lizett Ortiz de Ora1, Julia M Balsamo1, Kylie S Uyeda1
1Department of Chemistry, University of California, Irvine, California 92617, United States.
ACS chemical biology
|March 22, 2024
概括
肠道细菌,特别是Enterobacteriaceae,可以通过触发α-synuclein (α-syn) 聚合来启动帕金森病 (PD) 病理. 细菌酸盐的减少会产生氧化条件,促进肠道中的α-syn凝聚.
科学领域:
- 微生物学 微生物学
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
背景情况:
- 帕金森病 (PD) 涉及神经元中的α-syn聚合.
- 新出现的证据表明PD可能起源于肠道,α-syn聚合物扩散到大脑.
- 驱动肠道起源α-syn聚合的机制在很大程度上是未知的.
研究的目的:
- 研究肠道细菌在启动α-syn聚合中的作用.
- 探索细菌代谢和胃肠道中的α-syn病理之间的潜在联系.
主要方法:
- 在体外实验中使用大肠杆菌K-12和STC-1细胞.
- 细菌酸盐降解途径及其对多巴胺氧化作用的分析.
- 评估化物暴露引起的α-syn聚合.
主要成果:
- 发现肠杆菌菌类可以诱导α-syn聚合.
- 大肠杆菌K-12的酸盐呼吸产生酸盐,导致Fe2+氧化和氧化还氧化潜力.
- 氧化条件促进了多巴胺衍生的和α-syn聚合物的形成.
- 亚酸盐,但不含酸盐,在肠内分泌STC-1细胞中诱导α-syn聚合.
结论:
- 由肠道微生物群减少的细菌酸盐可能是启动肠道内α-syn聚合的关键因素.
- 这一过程可能代表某些帕金森病亚型的肠-大脑轴病理学的早期步骤.
相关概念视频
The Proteasome
832
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
832
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


